Related Experiment Video
Updated: May 5, 2026

Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model
Published on: June 20, 2025
MicroRNAs in Cerebral Ischemia
Kai-Ying Lim1, Jia-Hui Chua, Jun-Rong Tan
1Department of Biochemistry, The Stroke Program, Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, 8 Medical Drive, Singapore, 117597, Singapore.
Abstract:
Pathogenesis of cerebral ischemia has so far been described in the context of proteins and the pathways that they regulate. The discovery of biomarkers has also been focussed mainly on proteins and to some extent on the mRNAs that encode them. The knowledge on the role of microRNAs in understanding the pathogenesis of cerebral ischemia is still at its infancy. In this study, using rat models subjected to middle cerebral artery occlusion, we have profiled the microRNAs at different reperfusion times (0 to 48 h) to understand the progression of cerebral ischemia. We have also attempted to correlate the expression of microRNAs to treatment with an NMDA antagonist (MK801) and to protein expression with the hope of demonstrating the potential use of microRNAs as early biomarkers of stroke.
Insights
This study reveals microRNAs (miRNAs) as potential early biomarkers for cerebral ischemia. Profiling miRNAs in rat models shows their dynamic changes during stroke progression, offering new insights beyond protein biomarkers.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Cerebral ischemia pathogenesis traditionally focuses on proteins and their regulated pathways.
- Current biomarker discovery primarily targets proteins and their encoding mRNAs.
- The role of microRNAs (miRNAs) in cerebral ischemia is an emerging area of research.
Purpose of the Study:
- To profile microRNAs (miRNAs) during the progression of cerebral ischemia in a rat model.
- To investigate the correlation between miRNA expression, NMDA antagonist treatment (MK801), and protein expression.
- To explore the potential of miRNAs as early biomarkers for stroke.
Main Methods:
- Utilized rat models subjected to middle cerebral artery occlusion (MCAO).
- Performed microRNA profiling at various reperfusion times (0-48 hours).
- Correlated miRNA expression with NMDA antagonist treatment and protein levels.
Main Results:
- Identified dynamic changes in microRNA expression profiles following cerebral ischemia.
- Demonstrated correlations between specific miRNAs, therapeutic intervention (MK801), and protein expression patterns.
- Provided evidence for the potential utility of miRNAs in understanding stroke pathogenesis.
Conclusions:
- MicroRNAs represent a novel class of potential biomarkers for cerebral ischemia.
- Understanding miRNA dynamics offers new perspectives on stroke progression and treatment response.
- Further research into miRNAs could significantly advance early stroke detection and therapeutic strategies.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction

